William Michael Culver Md in Pollock Pines, CA - Clinic/Center

William Michael Culver Md is a primary clinic (Clinic/center - Primary Care) in Pollock Pines, California. The current practice location for William Michael Culver Md is 6156 Pony Express Trl, Pollock Pines, California. For appointments, you can reach them via phone at (530) 644-6044. The mailing address for William Michael Culver Md is 6156 Pony Express Trl, Pollock Pines, California and phone number is (530) 644-6044.

William Michael Culver Md is licensed to practice in California (license number G32582) and its NPI number is 1588973788. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (530) 644-6044.

Contact Information

	William Michael Culver Md
	6156 Pony Express Trl Pollock Pines CA 95726-9649
	(530) 644-6044
	(530) 644-0125

Primary Care Clinic Profile

Full Name	William Michael Culver Md
Speciality	Clinic/center - Primary Care
Location	6156 Pony Express Trl, Pollock Pines, California
Authorized Official Name and Position	William Michael Culver (CEO/PHYSICIAN)
Authorized Official Contact	5306446044
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Michael Culver Md 6156 Pony Express Trl Pollock Pines CA 95726-9649 Ph: (530) 644-6044	William Michael Culver Md 6156 Pony Express Trl Pollock Pines CA 95726-9649 Ph: (530) 644-6044

NPI Details:

NPI Number	1588973788
Provider Enumeration Date	10/05/2010
Last Update Date	02/16/2012

Medical Identifiers

Medical identifiers for William Michael Culver Md such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588973788	NPI	-	NPPES
4774218	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QP2300X	Clinic/center - Primary Care	G32582 (California)	Primary

News Archive

FDA wants new warnings on antidepressant medications

The U.S. Food and Drug Administration (FDA) has proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).

Curcumin emerges as prime candidate for less expensive AD treatment

The spice compound that gives curry dishes their yellow color and pungent flavor is emerging as a prime candidate for a less expensive treatment for Alzheimer's disease (AD), according to an article in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

ObamaCare can be a costly shift for people suffering with obstructive sleep apnea

Health insurance is a fast changing landscape in the United States with the implementation of ObamaCare, also known as The Affordable Health Care Act. Health insurance companies are doing something called cost shifting where the cost of care gets shifted onto the patients. For people who suffer with obstructive sleep apnea, this is can be a costly shift.

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.

William Michael Culver Md - Primary Care in Pollock Pines, CA